|
1
|
Vionnet J, Sempoux C, Pascual M,
Sánchez-Fueyo A and Colmenero J: Donor-specific antibodies in liver
transplantation. Gastroenterol Hepatol. 43:34–45. 2020.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
2
|
Kannabhiran D, Lee J, Schwartz JE,
Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan
SV, Kapur S, et al: Characteristics of circulating donor human
leukocyte antigen-specific immunoglobulin G antibodies predictive
of acute antibody-mediated rejection and kidney allograft failure.
Transplantation. 99:1156–1164. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mohan S, Palanisamy A, Tsapepas D,
Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ and Radhakrishnan
J: Donor-specific antibodies adversely affect kidney allograft
outcomes. J Am Soc Nephrol. 23:2061–2071. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Einecke G, Sis B, Reeve J, Mengel M,
Campbell PM, Hidalgo LG, Kaplan B and Halloran PF:
Antibody-mediated microcirculation injury is the major cause of
late kidney transplant failure. Am J Transplant. 9:2520–2531.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Venick RS, Farmer DG, McDiarmid SV, Duffy
JP, Gordon SA, Yersiz H, Hong JC, Vargas JH, Amment ME and Busuttil
RW: Predictors of survival following liver transplantation in
infants: A single-center analysis of more than 200 cases.
Transplantation. 89:600–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bishara A, Brautbar C, Eid A, Scherman L,
Ilan Y and Safadi R: Is presensitization relevant to liver
transplantation outcome? Hum Immunol. 63:742–750. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Muro M, López-Álvarez MR, Campillo JA,
Marin L, Moya-Quiles MR, Bolarin JM, Botella C, Salgado G, Martinez
P, Sánchez-Bueno F, et al: Influence of human leukocyte antigen
mismatching on rejection development and allograft survival in
liver transplantation: Is the relevance of HLA-A locus matching
being underestimated? Transpl Immunol. 26:88–93. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kaczmarek I, Deutsch MA, Kauke T,
Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B,
Spannagl M and Ueberfuhr P: Donor-specific HLA alloantibodies:
Long-term impact on cardiac allograft vasculopathy and mortality
after heart transplant. Exp Clin Transplant. 63:229–235.
2008.PubMed/NCBI
|
|
9
|
Smith JD, Banner NR, Hamour IM, Ozawa M,
Goh A, Robinson D, Terasaki PI and Rose ML: De novo donor
HLA-specific antibodies after heart transplantation are an
independent predictor of poor patient survival. Am J Transplant.
11:312–319. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Taner T, Gandhi MJ, Sanderson SO,
Poterucha CR, De Goey SR, Stegall MD and Heimbach JK: Prevalence,
course and impact of HLA donor-specific antibodies in liver
transplantation in the first year. Am J Transplant. 12:1504–1510.
2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Starzl TE, Demetris AJ, Todo S, Kang Y,
Tzakis A, Duquesnoy R, Makowka L, Banner B, Concepcion W and
Kendrick A: Evidence for hyperacute rejection of human liver
grafts: The case of the canary kidneys. Clin Transplant. 3:37–45.
1989.PubMed/NCBI
|
|
12
|
Kozlowski T, Rubinas T, Nickeleit V,
Woosley J, Schmitz J, Collins D, Hayashi P, Passannante A and
Andreoni K: Liver allograft antibody-mediated rejection with
demonstration of sinusoidal C4d staining and circulating
donor-specific antibodies. Liver Transpl. 17:357–368.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Paterno F, Shiller M, Tillery G, O'Leary
JG, Susskind B, Trotter J and Klintmalm GB: Bortezomib for acute
antibody-mediated rejection in liver transplantation. Am J
Transplant. 12:2526–2531. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Musat AI, Pigott CM, Ellis TM, Agni RM,
Leverson GE, Powell AJ, Richards KR, D'Alessandro AM and Lucey MR:
Pretransplant donor-specific anti-HLA antibodies as predictors of
early allograft rejection in ABO-compatible liver transplantation.
Liver Transpl. 19:1132–1141. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Musat AI, Agni RM, Wai PY, Pirsch JD,
Lorentzen DF, Powell A, Leverson GE, Bellingham JM, Fernandez LA,
Foley DP, et al: The significance of donor-specific HLA antibodies
in rejection and ductopenia development in ABO compatible liver
transplantation. Am J Transplant. 11:500–510. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Demetris AJ, Markus BH, Burnham J,
Nalesnik M, Gordon RD, Makowka L and Starzl TE: Antibody deposition
in liver allografts with chronic rejection. Transplant Proc. 19 (4
Suppl 5):S121–S125. 1987.PubMed/NCBI
|
|
17
|
Del Bello A, Congy-Jolivet N, Muscari F,
Lavayssière L, Esposito L, Cardeau-Desangles I, Guitard J, Dörr G,
Suc B, Duffas JP, et al: Prevalence, incidence and risk factors for
donor-specific anti-HLA antibodies in maintenance liver transplant
patients. Am J Transplant. 14:867–875. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Miyagawa-Hayashino A, Yoshizawa A, Uchida
Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S
and Haga H: Progressive graft fibrosis and donor-specific human
leukocyte antigen antibodies in pediatric late liver allografts.
Liver Transpl. 18:1333–3342. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Wozniak LJ, Hickey MJ, Venick RS, Vargas
JH, Farmer DG, Busuttil RW, McDiarmid SV and Reed EF:
Donor-specific HLA antibodies are associated with late allograft
dysfunction after pediatric liver transplantation. Transplantation.
99:1416–1422. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dalva K and Beksac M: HLA typing with
sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of
the Luminex technology. Methods Mol Med. 134:61–69. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yoshizawa A, Egawa H, Yurugi K, Hishida R,
Tsuji H, Ashihara E, Miyagawa-Hayashino A, Teramukai S, Maekawa T,
Haga H and Uemoto S: Significance of semiquantitative assessment of
preformed donor-specific antibody using luminex single bead assay
in living related liver transplantation. Clin Dev Immunol.
2013(972705)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen ZH: Problems and significance of
liver allograft as an immunologically privileged organ. Zhonghua
Gan Zang Bing Za Zhi. 13(221)2005.PubMed/NCBI(In Chinese).
|
|
23
|
Guo H: Brief summary of recent findings on
pathology of antibody-mediated rejection in organ transplantation.
Chin J Transplant (Electronic Edition). 6:138–143. 2012.
|
|
24
|
Zhou J and Shao CK: Advances of cellular
and molecular immunology of acute rejection in liver
transplantation. Chin J Organ Transplant. 6:381–383. 2007.
|
|
25
|
Valcnzucla NM, Hickey MJ and Reed EF:
Antibody subclass repertoire and graft outcome following solid
organ transplantation. Front Immunol. 7(433)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kaneku H, O'Leary JG, Bannuelos N, Jenning
LW, Susskind BM, Klintmalm GB and Terasaki PI: De novo
donor-specific HLA antibodies decrease patient and graft survival
in liver transplant recipients. Am J Transplant. 13:1541–1548.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
O'Leary JG and Klintmalm GB: Impact of
donor-specific antibodies on results of liver transplantation. Curr
Opin Organ Transplant. 18:279–284. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
O'Leary JG, Kaneku H, Jennings LW,
Banuelos N, Susskind BM, Terasaki PI and Klintmalm GB: Preformed
class II donor-specific antibodies are associated with an increased
risk of early rejection after liver transplantation. Liver Transpl.
19:973–980. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Böhming GA, Exner M, Habicht A,
Schillinger M, Lang U, Kletzmayr J, Säemann MD, Hörl WH,
Watschinger B and Regele H: Capillary C4d deposition in kidney
allografts: A specific marker of alloantibody-dependent graft
injury. J Am Soc Nephrol. 13:1091–1099. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ali S, Ormsby A, Shah V, Segovia MC, Kantz
KL, Skorupski S, Eisenbrey AB, Mahan M and Huang MA: Significance
of complement split product C4d in ABO-compatible liver allograft:
Diagnosing utility in acute antibody mediated rejection. Transpl
Immunol. 26:62–69. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Del Bello A, Congy-Jolivet N, Danjoux M,
Muscari F, Lavayssière L, Esposito L, Cardeau-Desangles I, Guitard
J, Dörr G, Milongo D, et al: De novo donor-specific anti-HLA
antibodies mediated rejection in liver-transplant patients. Transpl
Int. 28:1371–1382. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kovandova B, Slavcev A, Sekerkova Z,
Honsova E and Trunecka P: Antibody-mediated rejection after liver
transplantation-relevance of C1q and C3d-binding antibodies. HLA.
92 (Suppl 2):S34–S37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sutherland SM, Chen G, Sequeira FA, Lou
CD, Alexander SR and Tyan DB: Complement-fixing donor-specific
antibodies identified by a novel C1q assay are associated with
allograft loss. Pediatr Transplant. 16:12–17. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wilson CH, Agarwal K, Carter V, Burt AD,
Hübscher S, Talbot D, Jaques BC and Manas DM: Late humoral
rejection in a compliant ABO-compatible liver transplant recipient.
Transplantation. 82:988–989. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Watson R, Kozlowski T, Nickeleit V,
Woosley JT, Schmitz JL, Zacks SL, Fair JH, Gerber DA and Andreoni
KA: Isolated donor specific alloantibody-mediated rejection after
ABO compatible liver transplantation. Am J Transplant. 6:3022–3029.
2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kamar N, Lavayssière L, Muscari F, Selves
J, Guilbeau-Frugier C, Cardeau I, Esposito L, Cointault O, Nogier
MB, Peron JM, et al: Early plasmapheresis and rituximab for acute
humoral rejection after ABO-compatible liver transplantation. World
J Gastroenterol. 15:3426–3430. 2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Couchonnal E, Rivet C, Ducreux S,
Dumortier J, Bosch A, Boillot O, Collardeau-Frachon S, Dubois R,
Hervieu V, André P, et al: Deleterious impact of C3d-binding
donor-specific anti-HLA antibodies after pediatric liver
transplantation. Transpl Immunol. 45:8–14. 2017.PubMed/NCBI View Article : Google Scholar
|
